Brief: Vor Bio Announces $75 Million Private Placement With Tcgx
27/03/2026 12:01
Vor Biopharma Inc VOR.O: VOR BIO ANNOUNCES $75 MILLION PRIVATE PLACEMENT WITH TCGX VOR BIOPHARMA INC - BIO TO USE PROCEEDS TO ADVANCE TELITACICEPT CLINICAL DEVELOPMENT Source text: ID:nGNX6J6sGd Further company coverage: VOR.O
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning